L Montus Kid Forte Tablet is a combination medication containing Levocetirizine 2.5 mg and Montelukast 5 mg, formulated specifically for pediatric use to manage allergic conditions and respiratory disorders. Levocetirizine is a second-generation antihistamine that selectively inhibits peripheral H1 receptors, effectively reducing symptoms such as sneezing, nasal congestion, rhinorrhea, and itching associated with allergic rhinitis and chronic urticaria. Montelukast, a leukotriene receptor antagonist, blocks the action of leukotrienes, inflammatory mediators involved in bronchoconstriction, mucus production, and airway edema, thereby improving asthma control and preventing exercise-induced bronchospasm. The synergistic effect of these active ingredients provides comprehensive relief from allergic rhinitis and asthma symptoms in children. L Montus Kid Forte is generally well-tolerated, with a low incidence of sedation compared to first-generation antihistamines. It is indicated for the treatment of seasonal and perennial allergic rhinitis, chronic idiopathic urticaria, and as adjunctive therapy in pediatric asthma management. Dosage should be strictly followed as prescribed by a healthcare professional, considering the child’s age and clinical condition. Caution is advised in patients with hepatic or renal impairment, and potential drug interactions should be reviewed prior to initiation.